Sumgong, who last year became the first Kenyan woman to win Olympic gold in the marathon, tested positive for the banned blood-booster EPO (erythropoietin) in an out-of-competition test carried out by the sport’s governing body.
“While we are distressed to learn of the reports of Jemima Sumgong’s positive drug test, if true, they indicate that we are gaining ground in our long-standing fight against doping,” Tim Hadzima, general manager of the consortium, said in a statement.
“Given our policies, until the conclusion of Jemima Sumgong’s case and any potential appeal process, we will not name a Series X women’s champion,” he added.
Sumgong leads the standings for Series X, which concludes at the April 17 Boston Marathon.
World Marathon Majors (WMM) rules state that athletes found guilty of breaking anti-doping rules enforced by the governing body IAAF, World Anti-Doping Agency (WADA), national federations or any of the series’ individual races cannot win a title.
“The Abbott World Marathon Majors is committed to eradicating doping and we will continue to lead the way in introducing and campaigning for aggressive measures,” Hadzima said.
“To that end, we recently, in conjunction with the IAAF, built and funded one of the largest targeted testing pool of athletes, with an aim of requiring more than 150 individuals to submit to out-of-competition testing a minimum of six times a year.”
The 32-year-old will not be defending her London marathon title on April 23, the organizers announced on Friday.
“She is currently suspended from competition pending the B test and the outcome of the investigation,” chief executive Nick Bitel said in a statement.
If Sumgong’s B sample is confirmed as positive and she is subsequently banned, it would be a massive blow for Kenya, where her Rio victory was greeted with near-delirium after a long barren spell over the classic distance at the Olympics.
Sumgong, who last year became the first Kenyan woman to win Olympic gold in the marathon, tested positive for the banned blood-booster EPO (erythropoietin) in an out-of-competition test carried out by the sport’s governing body.
“While we are distressed to learn of the reports of Jemima Sumgong’s positive drug test, if true, they indicate that we are gaining ground in our long-standing fight against doping,” Tim Hadzima, general manager of the consortium, said in a statement.
“Given our policies, until the conclusion of Jemima Sumgong’s case and any potential appeal process, we will not name a Series X women’s champion,” he added.
Sumgong leads the standings for Series X, which concludes at the April 17 Boston Marathon.
World Marathon Majors (WMM) rules state that athletes found guilty of breaking anti-doping rules enforced by the governing body IAAF, World Anti-Doping Agency (WADA), national federations or any of the series’ individual races cannot win a title.
“The Abbott World Marathon Majors is committed to eradicating doping and we will continue to lead the way in introducing and campaigning for aggressive measures,” Hadzima said.
“To that end, we recently, in conjunction with the IAAF, built and funded one of the largest targeted testing pool of athletes, with an aim of requiring more than 150 individuals to submit to out-of-competition testing a minimum of six times a year.”
The 32-year-old will not be defending her London marathon title on April 23, the organizers announced on Friday.
“She is currently suspended from competition pending the B test and the outcome of the investigation,” chief executive Nick Bitel said in a statement. “Sumgong will therefore not run in London on 23 April to defend the title she won last year.”
If Sumgong’s B sample is confirmed as positive and she is subsequently banned, it would be a massive blow for Kenya, where her Rio victory was greeted with near-delirium after a long barren spell over the classic distance at the Olympics.
